Back

Severe acute respiratory syndrome coronavirus 2 infection, angiotensin-converting enzyme 2 and treatment with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers - Discussion

16 April 2021 (16:07 - 16:20)
Organised by:
Congress Presentation Part of: Let´s look at 2020´s most downloaded articles in the European Journal of Preventive Cardiology (EJPC) Risk Factors and Prevention EAPC Premium Access ESC Preventive Cardiology 2021

7 More presentations in this session

Presentation thumbnail
Skipping breakfast concomitant with late-night dinner eating is associated with worse outcomes following ST-segment elevation myocardial infarction
Mr G. Neif Vieira Musse (Sao Paulo, BR)
Video
Presentation thumbnail
Skipping breakfast concomitant with late-night dinner eating is associated with worse outcomes following ST-segment elevation myocardial infarction - Commentary
Professor M. Minicucci (Botucatu, BR)
Video
Presentation thumbnail
Skipping breakfast concomitant with late-night dinner eating is associated with worse outcomes following ST-segment elevation myocardial infarction - discussion
Presentation thumbnail
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
Doctor C. Ballantyne (Houston, US)
Video
Presentation thumbnail
Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy - Commentary.
Professor U. Landmesser (Berlin, DE)

Access the full session

Session thumbnail
Let´s look at 2020´s most downloaded articles in the European Journal of Preventive Cardiology (EJPC)
Video

The Event

Event poster

ESC Preventive Cardiology 2021

16 April 2021 16:07 CET
You may be interested in
thumbnail
Congress Presentation
COVID-19-induced heart failure: pathophysiologic mechanisms, and their relevance to clinical practice.
21 May 2022
thumbnail
Congress Presentation
Angiotensin-converting enzyme inhibitors for aortic stenosis: a drug-target mendelian randomisation study
1 September 2025
thumbnail
Congress Presentation
Cardioprotective effect of angiotensin converting enzyme 2 activation in hESC-derived cardiomyocytes under diabetic condition
21 May 2023
thumbnail
Congress Presentation
Evaluation of cardiorespiratory status of subjects after sars cov 2 infection and the potential role of hypertension as a negative risk factor
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources